Unknown

Dataset Information

0

Addressing cellular heterogeneity in tumor and circulation for refined prognostication.


ABSTRACT: Despite pronounced genomic and transcriptomic heterogeneity in non-small-cell lung cancer (NSCLC) not only between tumors, but also within a tumor, validation of clinically relevant gene signatures for prognostication has relied upon single-tissue samples, including 2 commercially available multigene tests (MGTs). Here we report an unanticipated impact of intratumor heterogeneity (ITH) on risk prediction of recurrence in NSCLC, underscoring the need for a better genomic strategy to refine prognostication. By leveraging label-free, inertial-focusing microfluidic approaches in retrieving circulating tumor cells (CTCs) at single-cell resolution, we further identified specific gene signatures with distinct expression profiles in CTCs from patients with differing metastatic potential. Notably, a refined prognostic risk model that reconciles the level of ITH and CTC-derived gene expression data outperformed the initial classifier in predicting recurrence-free survival (RFS). We propose tailored approaches to providing reliable risk estimates while accounting for ITH-driven variance in NSCLC.

SUBMITTER: Lim SB 

PROVIDER: S-EPMC6731691 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Addressing cellular heterogeneity in tumor and circulation for refined prognostication.

Lim Su Bin SB   Yeo Trifanny T   Lee Wen Di WD   Bhagat Ali Asgar S AAS   Tan Swee Jin SJ   Tan Daniel Shao Weng DSW   Lim Wan-Teck WT   Lim Chwee Teck CT  

Proceedings of the National Academy of Sciences of the United States of America 20190815 36


Despite pronounced genomic and transcriptomic heterogeneity in non-small-cell lung cancer (NSCLC) not only between tumors, but also within a tumor, validation of clinically relevant gene signatures for prognostication has relied upon single-tissue samples, including 2 commercially available multigene tests (MGTs). Here we report an unanticipated impact of intratumor heterogeneity (ITH) on risk prediction of recurrence in NSCLC, underscoring the need for a better genomic strategy to refine progno  ...[more]

Similar Datasets

| S-EPMC3975231 | biostudies-literature
| S-EPMC8982370 | biostudies-literature
| S-EPMC4022236 | biostudies-literature
| S-EPMC7492900 | biostudies-literature
| S-EPMC6355487 | biostudies-literature
| S-EPMC4697694 | biostudies-literature
| S-EPMC5507536 | biostudies-literature
| S-EPMC6514366 | biostudies-literature
| S-EPMC10897978 | biostudies-literature
| S-EPMC7496557 | biostudies-literature